In a retrospective cohort of 262 patients with AAV, adding CT-measured kidney volume to creatinine and C3 increased the accuracy of 3-year ESRD prediction, although the increase was not statistically ...

Across 11 AAV guidelines, applicability received the lowest mean score (54%), with none exceeding 70%; patient involvement, implementation tools, and monitoring criteria were key areas for improvement ...

Obinutuzumab shows preliminary efficacy and safety in adolescents with active lupus nephritis. Investigators presented primary findings from the POSTERITY phase 2 trial at the American Society of ...

Daratumumab was associated with rapid improvement in serology in the 9 patients with active lupus nephritis, but some relapses occurred.

The new Kidney Care National Plan from the US Department of Health and Human Services focuses on preventing kidney failure, ...

The VOICE trial examined clinical outcomes and safety after administering vadadustat vs EPO during thrice-weekly hemodialysis ...

Mean percentage of time that CGM-measured glucose level was in range of 70 to 180 mg/dL was 21 percentage points higher with CGM.

In a survey study, surrogates were less likely to recommend LST for patients with versus without dementia, even when advance directives request all care possible.

Crude odds ratios suggest increased risk for AMD, which was reversed after accounting for cardiometabolic confounders.

An investigator reported the results of a prespecified interim analysis of the phase 3 I CAN trial of ravulizumab for immunoglobulin A nephropathy.

Participants in the treatment group experienced a 93.5% reduction in urine soluble C5b9 levels from baseline to 24 months.

Telitacicept was associated with 6 times the odds of a decrease in proteinuria compared with immunosuppressive treatment at 48 weeks.